L&C Bio Co Ltd (290650.KO) Quotes and Fundamentals

Piotroski F-Score

5 / 9

Neutral

Beneish M-Score

-3.94

Highly reliable

1-Year Forecast

45,250

Transformational upside

Relative Strength

5 / 100

Severely lagging

Debt / Equity

0.20

Very low leverage

Pre-Tax Margin

-128%

Severely loss-making

Business Description

Founded in 2011 and based in Seongnam-si, South Korea, L&C Bio develops products that help repair and restore human tissue. The company's work spans medical treatments, tissue-based medical devices, and cosmetic products. Its research-driven approach positions it at the intersection of healthcare and personal care innovation.

Key Fundamentals

EPS-6,013

ROE-57.52

RPS2,325

ROIC3.76

ROA-31.19

Interest Cover0.18

EBITDA, mln-27,998

EV / EBITDA-56.35

EV / EBIT-39.61

Revenue, mln116,304

EV / Revenue13.56

Quote Details

Last 24,950

Change 1150 (4.83%)

Open 24,000

Volume 191,599

Turnover 4,780,395,008

Average Volume 749,362

Financial Ratios

Pre-Tax Profit Margin-128

Current Ratio1.33

Price / Book4.27

Price / Tangible Book7.02

Debt / Equity0.20

Price / Sales11.39

Financial Strength

Altman Z-Score6.91

Piotroski F-Score 5 / 9

Beneish M-Score-3.94

Price to Intrinsic Value40.02

1-Year Target Price45,250

Shiller PE Ratio91.44

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-22.4%	1 / 100
1 Month	5.72%	90 / 100
2 Months	-29.72%	6 / 100
6 Months	-27.37%	44 / 100
1 Year	-5.24%	56 / 100